SCHEMBL7057542

SCHEMBL7057542

CCN(CC)c1ccc(/N=C/c2ccc(N(CC)CC)cc2O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 17/20 1.00
ALDH1A1 P00352 16/20 1.00
KDM4E B2RXH2 10/20 1.00
KMT2A Q03164 6/20 1.00
MEN1 O00255 5/20 1.00
LMNA P02545 4/20 1.00
TDP1 Q9NUW8 3/20 1.00
CRHBP P24387 1/20 1.00
CRHR2 Q13324 1/20 1.00
GAA P10253 8/20 0.86
HTT P42858 3/20 0.86
THRB P10828 2/20 0.86
NPSR1 Q6W5P4 1/20 0.86
HPGD P15428 4/20 0.78
USP2 O75604 1/20 0.78
BLM P54132 1/20 0.77
MAPK1 P28482 2/20 0.67
RAB9A P51151 4/20 0.65
NPC1 O15118 2/20 0.65
SMN1; SMN2 Q16637 3/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7057544 1.00 MAPT (1.00) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL31026882 0.91 MAPT (1.00) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL12548617 0.91 MAPT (1.00) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL12548110 0.89 MAPT (0.80) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL12548388 0.87 MAPT (0.77) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL10490301 0.86 ALDH1A1 (0.74) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL29394246 0.86 MAPT (0.79) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL11327357 0.85 MAPT (0.74) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL11327352 0.85 MAPT (0.74) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL22299740 0.84 MAPT (0.72) MAPTALDH1A1KDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230136466-A1 BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2023-05-04 US disclosed
US-20230136466-A1 BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2023-05-04 US disclosed
US-8758897-B2 Schiff base type color conversion layer, light absorbing layer, and filter ADEKA CORPORATION (JP) 2014-06-24 US disclosed
US-8758897-B2 Schiff base type color conversion layer, light absorbing layer, and filter ADEKA CORPORATION (JP) 2014-06-24 US disclosed
US-8568884-B2 Schiff base type compound and coloring material containing the same ADEKA CORPORATION (JP) 2013-10-29 US disclosed
US-8568884-B2 Schiff base type compound and coloring material containing the same ADEKA CORPORATION (JP) 2013-10-29 US disclosed
US-20130252024-A1 SCHIFF BASE TYPE COLOR CONVERSION LAYER, LIGHT ABSORBING LAYER, AND FILTER ADEKA CORPORATION (JP) 2013-09-26 US disclosed
US-20130252024-A1 SCHIFF BASE TYPE COLOR CONVERSION LAYER, LIGHT ABSORBING LAYER, AND FILTER ADEKA CORPORATION (JP) 2013-09-26 US disclosed
US-20110135958-A1 SCHIFF BASE TYPE COMPOUND AND COLORING MATERIAL CONTAINING THE SAME ADEKA CORPORATION (JP) 2011-06-09 US disclosed
US-20110135958-A1 SCHIFF BASE TYPE COMPOUND AND COLORING MATERIAL CONTAINING THE SAME ADEKA CORPORATION (JP) 2011-06-09 US disclosed
US-20030138374-A1 Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same BF RESEARCH INSTITUTE, INC. (JP) 2003-07-24 US disclosed
EP-1266884-A1 IMAGE DIAGNOSIS PROBE BASED ON SUBSTITUTED AZOBENZENE OR ANALOGUE THEREOF FOR DISEASE ATTRIBUTABLE TO AMYLOID ACCUMULATION AND COMPOSITION FOR IMAGE DIAGNOSIS CONTAINING THE SAME BF Research Institute, Inc. (JP) 2002-12-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030138374-A1 Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same APBA1, S100B, APP MAPT 124/4885ALDH1A1 2139/4885KDM4E 3711/4885
US-20230136466-A1 BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF TOP1, DNA2, TOP2A MAPT 3260/4885ALDH1A1 4377/4885KDM4E 2244/4885
US-20110135958-A1 SCHIFF BASE TYPE COMPOUND AND COLORING MATERIAL CONTAINING THE SAME ALDH1A2, ASIC1, IK MAPT 3058/4885ALDH1A1 12/4885KDM4E 1338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.